Hermann Gram

Title: Hermann Gram: Innovator in Monoclonal Antibody Development

Introduction

Hermann Gram is a notable inventor based in Weil-Haltingen, Germany. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His work focuses on addressing endotoxemia caused by Gram-negative bacterial strains.

Latest Patents

Hermann Gram holds a patent for a monoclonal antibody against LPS core. This invention provides monoclonal antibodies (Mabs) that are cross-protective against endotoxemia caused by at least two different Gram-negative bacterial strains with varying core structures. The methods of production for these antibodies involve the Kohler/Milstein procedure, which includes immunizing mice with different rough strains of heat-killed Gram-negative bacteria, followed by fusion and screening of the resulting hybridomas. The murine MAbs can be chimerized or humanized using established methods.

Career Highlights

Hermann Gram's career is marked by his innovative approach to antibody development. His patent demonstrates a deep understanding of immunological responses and the potential for creating effective treatments against bacterial infections. His work has implications for both therapeutic applications and research in the field of immunology.

Collaborations

Hermann has collaborated with notable colleagues, including Franco Di Padova and George Robin Barclay. These partnerships have likely contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Hermann Gram's contributions to the field of monoclonal antibodies highlight his role as an innovator in immunology. His patent for a monoclonal antibody against LPS core showcases the potential for cross-protective treatments against Gram-negative bacterial infections.